Stockscreener 앱 받기
0.71
2.85%
0.0197
시장 영업 전:
.71
전일 마감가:
$0.6903
열려 있는:
$0.69
하루 거래량:
16,927
Relative Volume:
0.05
시가총액:
$54.95M
수익:
$234.00K
순이익/손실:
$-23.11M
주가수익비율:
-0.6899
EPS:
-1.0292
순현금흐름:
$-20.71M
1주 성능:
-2.75%
1개월 성능:
+0.71%
6개월 성능:
+1.57%
1년 성능:
-44.09%
1일 변동 폭
$0.69
$0.7199
1주일 범위
$0.69
$0.7301
52주 변동 폭
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
명칭
Envoy Medical Inc
전화
651-361-8000
주소
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.71 | 54.95M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
103.36 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 개시 | H.C. Wainwright | Buy |
| 2024-06-24 | 개시 | Ascendiant Capital Markets | Buy |
Envoy Medical Inc 주식(COCH)의 최신 뉴스
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCHW - tradingview.com
COCH News | ENVOY MEDICAL INC (NASDAQ:COCH) - ChartMill
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical Inc. (NASDAQ: COCH) Share Price, COCH Stock News, COCH Share Price & Updates - kalkine.ca
Envoy Medical CEO to present fully implanted he... - Pluang
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th - Yahoo Finance
Envoy Medical CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
Envoy Medical (NASDAQ: COCH) weighs 1‑for‑25 reverse split to avoid delisting - Stock Titan
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical names Robert Potashnick Chief Accounting Officer and VP of Finance - tradingview.com
Envoy Medical (COCH) awards 250K options to Potashnick - Stock Titan
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
HC Wainwright Cuts Envoy Medical (NASDAQ:COCH) Price Target to $2.00 - MarketBeat
H.C. Wainwright cuts Envoy Medical stock price target on share count - Investing.com Canada
COCH Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Envoy (COCH) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Price Move - vinanet.vn
Envoy (COCH) Q1 2026 Earnings: The Bottom-Line Figure Beats Its Comparison for the Current Session - vinanet.vn
Envoy (COCHW) Momentum: Trades in a Narrow Directional Range at $0.05 at the Close - vinanet.vn
Envoy Medical Warrant (COCHW) Holds at $0.05 as Flat Trading PersistsBullish Percent Index - Vinanet
Price to sales forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street Its The Platformsinvestor distribution. - ACCESS Newswire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA - Caledonian Record
The Beat: Target names AI chief, Niron gets White House backing, Envoy chases cochlear market - The Business Journals
Envoy Medical Inc. (NASDAQ: COCHW) Stock Price, News & Analysis - Kalkine
Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors - TipRanks
Envoy Medical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Envoy Medical earnings beat, revenue fell short of estimates - Investing.com
Envoy Medical (NASDAQ: COCH) raises cash, advances fully implanted cochlear implant - Stock Titan
Envoy Medical Releases Q2 2026 Financial Results - AlphaStreet
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Envoy Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise - Stock Titan
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCHW - TradingView
Envoy Medical (COCH) Reports Q2 2026 Results, Submits First FDA PMA Module and Posts Strong Acclaim® Cochlear Implant Clinical Data - kalkine.ca
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical (COCH) Holds Near $0.68 as Hearing Implant Developer Digests Post-Listing VolatilityEntry Point Alerts - vinanet.vn
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial - newswire.com
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 3.61% Share GainEarnings Trend Analysis - Vinanet
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCHW - TradingView
Envoy Medical, Inc. Revenue Breakdown – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Capital Markets initiates Envoy Medical stock with buy rating By Investing.com - Investing.com Canada
Envoy Medical Inc (COCH) Cash Flow - TradingKey
Envoy Medical Inc (COCH) Income Statement - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Warrants Edge Higher Amidst Tight Trading RangeMAMA Signal - dars.gov.et
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
COCH Q1 2026 Earnings: EPS Surprises by 65%, Exceeding ExpectationsEPS Surprise History - vinanet.vn
Envoy Medical Inc (COCH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Envoy Medical Inc 주식 (COCH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
2.29%
0.75%
자본화:
|
볼륨(24시간):